Is nayzilam used for status epilepticus?

What is Nayzilam and how does it stop seizures?

Nayzilam is a nasal spray containing midazolam that delivers the drug quickly through the nasal mucosa into the brain. It binds to GABA receptors to enhance inhibitory signals, stopping clusters of seizures or prolonged activity before it escalates.

Does Nayzilam treat status epilepticus?

Nayzilam is FDA-approved for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity, such as acute repetitive seizures or seizure clusters. It is not indicated for status epilepticus.

How does Nayzilam fit into seizure care protocols?

Nayzilam provides at-home rescue for patients who experience recurrent seizures before they reach 5 minutes per seizure or 5 minutes between them. When a patient meets clinical criteria for status epilepticus, clinicians typically turn to intravenous benzodiazepines or other agents.

What happens if someone uses Nayzilam during status epilepticus?

If used during status epilepticus, Nayzilam can serve as a bridge until professional medical care arrives. It may slow or stop continuing activity in some cases, but official guidelines still recommend IV access for persistent or convulsive status.

Can Nayzilam compete with established rescue medications?

Nayzilam competes mainly with rectal diazepam (Diastat) and oral clonazepam wafers. It offers non-invasive nasal delivery while maintaining comparable efficacy in stopping cluster seizures.